For the quarter ending 2025-09-30, PMN has $21,458,147 in assets. $12,270,792 in debts. $15,399,165 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 15,399,165 | 4,510,119 | ||
| Short-term investments | 33,051 | 33,051 | ||
| Prepaid expenses and other current assets | 6,025,931 | 4,966,326 | ||
| Total current assets | 21,458,147 | 9,509,496 | ||
| Total assets | 21,458,147 | 9,509,496 | ||
| Accounts payable | 4,211,485 | 2,780,179 | ||
| Accrued liabilities | 7,999,562 | 7,043,908 | ||
| Total current liabilities | 12,211,047 | 9,824,087 | ||
| Share-based compensation liability | 54,153 | 62,395 | ||
| Warrant liability | 5,592 | 5,592 | ||
| Common shares, no par value, unlimited shares authorized, 32,689,190 shares issued and outstanding as of june 30, 2025 and december 31, 2024 | - | 0 | ||
| Total liabilities | 12,270,792 | 9,892,074 | ||
| Additional paid-in capital | 129,290,671 | 108,140,611 | ||
| Accumulated other comprehensive loss | -371,184 | -371,184 | ||
| Accumulated deficit | -119,732,132 | -108,152,005 | ||
| Total shareholders' equity | 9,187,355 | -382,578 | ||
| Total liabilities and shareholders' equity | 21,458,147 | 9,509,496 | ||
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)